Lung

Type of Cancer: Lung

Sponsor: Mirati

Phase / Design: A Randomized Phase 3 Study of MRTX849 versus Docetaxel

Population: Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

COVID-19
Myeloma
Menu